Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging
Autor: | Simonetta Gerevini, Mauro Monforte, M. Gros, Sabrina Sacconi, Giancarlo Deidda, Jordi Díaz-Manera, Enzo Ricci, Lara Cristiano, Volker Straub, G. Giacomucci, C. Marini Bettolo, Giorgio Tasca, Lorenzo Maggi, B.G.M. van Engelen, Emiliano Giardina, Jana Haberlová, Pilar Camaño, Tommaso Tartaglione, Karlien Mul, John Vissing, Julia R. Dahlqvist, Patrizia Calandra, R. Fernandez Torron |
---|---|
Rok vydání: | 2020 |
Předmět: |
Iliopsoas Muscle
facioscapulohumeral muscular dystrophy neuromuscular diseases FSHD2 03 medical and health sciences 0302 clinical medicine Humans Medicine Facioscapulohumeral muscular dystrophy 030212 general & internal medicine Muscle Skeletal Gluteus minimus muscle FSHD business.industry Subscapularis muscle Anatomy Levator scapulae muscle Disorders of movement Donders Center for Medical Neuroscience [Radboudumc 3] medicine.disease Magnetic Resonance Imaging Muscular Dystrophy Facioscapulohumeral body regions Settore MED/26 - NEUROLOGIA Lower Extremity Neurology Neurology (clinical) Iliopsoas business Trapezius muscle Sternocleidomastoid muscle 030217 neurology & neurosurgery muscle MRI |
Zdroj: | EUROPEAN JOURNAL OF NEUROLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname European Journal of Neurology, 27, 12, pp. 2604-2615 European Journal of Neurology, 27, 2604-2615 European journal of neurology 27 (2020): 2604–2615. doi:10.1111/ene.14446 info:cnr-pdr/source/autori:Giacomucci G.; Monforte M.; Diaz-Manera J.; Mul K.; Fernandez Torron R.; Maggi L.; Marini Bettolo C.; Dahlqvist J.R.; Haberlova J.; Camano P.; Gros M.; Tartaglione T.; Cristiano L.; Gerevini S.; Calandra P.; Deidda G.; Giardina E.; Sacconi S.; Straub V.; Vissing J.; Van Engelen B.; Ricci E.; Tasca G./titolo:Deep phenotyping of facioscapulohumeral muscular dystrophy type 2 by magnetic resonance imaging/doi:10.1111%2Fene.14446/rivista:European journal of neurology (Print)/anno:2020/pagina_da:2604/pagina_a:2615/intervallo_pagine:2604–2615/volume:27 r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau) |
ISSN: | 1351-5101 |
DOI: | 10.1111/ene.14446 |
Popis: | Contains fulltext : 229735.pdf (Publisher’s version ) (Closed access) BACKGROUND AND PURPOSE: The aim was to define the radiological picture of facioscapulohumeral muscular dystrophy 2 (FSHD2) in comparison with FSHD1 and to explore correlations between imaging and clinical/molecular data. METHODS: Upper girdle and/or lower limb muscle magnetic resonance imaging scans of 34 molecularly confirmed FSHD2 patients from nine European neuromuscular centres were analysed. T1-weighted and short-tau inversion recovery (STIR) sequences were used to evaluate the global pattern and to assess the extent of fatty replacement and muscle oedema. RESULTS: The most frequently affected muscles were obliquus and transversus abdominis, semimembranosus, soleus and gluteus minimus in the lower limbs; trapezius, serratus anterior, latissimus dorsi and pectoralis major in the upper girdle. Iliopsoas, popliteus, obturator internus and tibialis posterior in the lower limbs and subscapularis, spinati, sternocleidomastoid and levator scapulae in the upper girdle were the most spared. Asymmetry and STIR hyperintensities were consistent features. The pattern of muscle involvement was similar to that of FSHD1, and the combined involvement of trapezius, abdominal and hamstring muscles, together with complete sparing of iliopsoas and subscapularis, was detected in 91% of patients. Peculiar differences were identified in a rostro-caudal gradient, a predominant involvement of lower limb muscles compared to the upper girdle, and in the higher percentage of STIR hyperintensities in FSHD2. CONCLUSION: This multicentre study defines the pattern of muscle involvement in FSHD2, providing useful information for diagnostics and clinical trial design. Both similarities and differences between FSHD1 and FSHD2 were detected, which is also relevant to better understand the pathogenic mechanisms underlying the FSHD-related disease spectrum. |
Databáze: | OpenAIRE |
Externí odkaz: |